newsfilter
← Latest News
GlobeNewswire·

Neoleukin Therapeutics to Host 2021 Financial Results Conference Call and Webcast on March 1, 2022

SEATTLE, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced , today announced it